Terms: = Prostate cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
81 results:
1. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
[TBL] [Abstract] [Full Text] [Related]
2. Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive prostate cancer.
Mitchell AP; Nemirovsky D; Mishra Meza A; Chakraborty N; Persaud S; Farooki A; Morris MJ
JCO Oncol Pract; 2024 Mar; 20(3):393-400. PubMed ID: 38190588
[TBL] [Abstract] [Full Text] [Related]
3. Mobile Phone Use and Risks of Overall and 25 Site-Specific cancers: A Prospective Study from the UK Biobank Study.
Zhang Y; Zhang Y; Ye Z; Yang S; Liu M; Wu Q; Zhou C; He P; Gan X; Qin X
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):88-95. PubMed ID: 37870426
[TBL] [Abstract] [Full Text] [Related]
4. Disparities Associated with Shared Decision-making in prostate cancer Screening.
Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
[TBL] [Abstract] [Full Text] [Related]
5. A preoperative magnetic resonance imaging-based model to predict biochemical failure after radical prostatectomy.
Pan M; Li S; Liu F; Liang L; Shang J; Xia W; Cheng G; Hua L
Sci Rep; 2023 Jan; 13(1):452. PubMed ID: 36624154
[TBL] [Abstract] [Full Text] [Related]
6. Correlations between serum levels of microRNA-148a-3p and microRNA-485-5p and the progression and recurrence of prostate cancer.
He W; Zhang F; Jiang F; Liu H; Wang G
BMC Urol; 2022 Nov; 22(1):195. PubMed ID: 36434610
[TBL] [Abstract] [Full Text] [Related]
7. Three-dimensional amide proton transfer-weighted and intravoxel incoherent motion imaging for predicting bone metastasis in patients with prostate cancer: A pilot study.
Hu W; Chen L; Lin L; Wang J; Wang N; Liu A
Magn Reson Imaging; 2023 Feb; 96():8-16. PubMed ID: 36375760
[TBL] [Abstract] [Full Text] [Related]
8. The 2018 World cancer Research Fund/American Institute for cancer Research Score and cancer Risk: A Longitudinal Analysis in the NIH-AARP Diet and Health Study.
Korn AR; Reedy J; Brockton NT; Kahle LL; Mitrou P; Shams-White MM
Cancer Epidemiol Biomarkers Prev; 2022 Oct; 31(10):1983-1992. PubMed ID: 35877953
[TBL] [Abstract] [Full Text] [Related]
9. No Association Between Polygenic Risk Scores for cancer and Development of Radiation Therapy Toxicity.
Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
[TBL] [Abstract] [Full Text] [Related]
10. Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan.
Shiota M; De Moor R; Koroki Y; Yu DY; Wu DB
Curr Med Res Opin; 2022 Aug; 38(8):1351-1359. PubMed ID: 35770513
[TBL] [Abstract] [Full Text] [Related]
11. High IL-23+ cells infiltration correlates with worse clinical outcomes and abiraterone effectiveness in patients with prostate cancer.
Liu Z; Zhang JY; Yang YJ; Chang K; Wang QF; Kong YY; Dai B
Asian J Androl; 2022; 24(2):147-153. PubMed ID: 34755700
[TBL] [Abstract] [Full Text] [Related]
12. Predictors for the utilization of social service counseling by prostate cancer patients.
Breidenbach C; Ansmann L; Sibert NT; Wesselmann S; Dieng S; Carl EG; Feick G; Stoklossa C; Taubert A; Pomery A; Beyer B; Blana A; Brock M; Distler F; Enge M; Gaber AA; Gilfrich C; Hinkel A; Kaftan B; Knoll T; Kunath F; Oostdam SJ; Peters I; Polat B; Schrodi V; Zengerling F; Kowalski C
Support Care Cancer; 2022 Mar; 30(3):2327-2339. PubMed ID: 34738162
[TBL] [Abstract] [Full Text] [Related]
13. Implications of a new element in the early diagnostic pathway for prostate cancer for rural Australians.
Macneil J; Wilkins R; Whelan C
Aust J Rural Health; 2021 Aug; 29(4):601-605. PubMed ID: 34351668
[TBL] [Abstract] [Full Text] [Related]
14. Patients' preferences for delaying metastatic castration-resistant prostate cancer: Combining health state and treatment valuation.
Rentz AM; Mansukhani SG; Liu J; Lloyd AJ; Heidenreich S; Matza LS; Dawson NA; Shore N; Freedland SJ
Urol Oncol; 2021 Jun; 39(6):367.e7-367.e17. PubMed ID: 33736976
[TBL] [Abstract] [Full Text] [Related]
15. Trends for Stage and Grade Group of prostate cancer in the US (2010-2016).
Schmanke K; Okut H; Ablah E
Urology; 2021 Mar; 149():110-116. PubMed ID: 33227304
[TBL] [Abstract] [Full Text] [Related]
16. Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy.
Prabhu N; Kapur N; Catalona W; Leikin R; Helenowski I; Jovanovich B; Gurley M; Okwuosa TM; Kuzel TM
Urol Oncol; 2021 Feb; 39(2):130.e9-130.e15. PubMed ID: 33132024
[TBL] [Abstract] [Full Text] [Related]
17. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study).
Weitzer J; Castaño-Vinyals G; Aragonés N; Gómez-Acebo I; Guevara M; Amiano P; Martín V; Molina-Barceló A; Alguacil J; Moreno V; Suarez-Calleja C; Jiménez-Moleón JJ; Marcos-Gragera R; Papantoniou K; Pérez-Gómez B; Llorca J; Ascunce N; Gil L; Gracia-Lavedan E; Casabonne D; Lope V; Pollán M; Kogevinas M
Int J Cancer; 2021 Mar; 148(6):1360-1371. PubMed ID: 32976649
[TBL] [Abstract] [Full Text] [Related]
18. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract] [Full Text] [Related]
19. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
[TBL] [Abstract] [Full Text] [Related]
20. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L
Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205
[TBL] [Abstract] [Full Text] [Related]
[Next]
